Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

147 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies.
Bártek J, Bártková J, Vojtĕsek B, Stasková Z, Lukás J, Rejthar A, Kovarík J, Midgley CA, Gannon JV, Lane DP. Bártek J, et al. Among authors: bartkova j. Oncogene. 1991 Sep;6(9):1699-703. Oncogene. 1991. PMID: 1923535
Tumors overexpressing RNF168 show altered DNA repair and responses to genotoxic treatments, genomic instability and resistance to proteotoxic stress.
Chroma K, Mistrik M, Moudry P, Gursky J, Liptay M, Strauss R, Skrott Z, Vrtel R, Bartkova J, Kramara J, Bartek J. Chroma K, et al. Among authors: bartkova j. Oncogene. 2017 Apr 27;36(17):2405-2422. doi: 10.1038/onc.2016.392. Epub 2016 Nov 14. Oncogene. 2017. PMID: 27841863
A high resolution genomic portrait of bladder cancer: correlation between genomic aberrations and the DNA damage response.
Schepeler T, Lamy P, Hvidberg V, Laurberg JR, Fristrup N, Reinert T, Bartkova J, Tropia L, Bartek J, Halazonetis TD, Pan CC, Borre M, Dyrskjøt L, Orntoft TF. Schepeler T, et al. Among authors: bartkova j. Oncogene. 2013 Aug 1;32(31):3577-86. doi: 10.1038/onc.2012.381. Epub 2012 Aug 27. Oncogene. 2013. PMID: 22926521
The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer.
Tommiska J, Bartkova J, Heinonen M, Hautala L, Kilpivaara O, Eerola H, Aittomäki K, Hofstetter B, Lukas J, von Smitten K, Blomqvist C, Ristimäki A, Heikkilä P, Bartek J, Nevanlinna H. Tommiska J, et al. Among authors: bartkova j. Oncogene. 2008 Apr 10;27(17):2501-6. doi: 10.1038/sj.onc.1210885. Epub 2007 Nov 5. Oncogene. 2008. PMID: 17982490
DNA damage signalling guards against activated oncogenes and tumour progression.
Bartek J, Bartkova J, Lukas J. Bartek J, et al. Among authors: bartkova j. Oncogene. 2007 Dec 10;26(56):7773-9. doi: 10.1038/sj.onc.1210881. Oncogene. 2007. PMID: 18066090 Review.
53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers.
Bouwman P, Aly A, Escandell JM, Pieterse M, Bartkova J, van der Gulden H, Hiddingh S, Thanasoula M, Kulkarni A, Yang Q, Haffty BG, Tommiska J, Blomqvist C, Drapkin R, Adams DJ, Nevanlinna H, Bartek J, Tarsounas M, Ganesan S, Jonkers J. Bouwman P, et al. Among authors: bartkova j. Nat Struct Mol Biol. 2010 Jun;17(6):688-95. doi: 10.1038/nsmb.1831. Epub 2010 May 9. Nat Struct Mol Biol. 2010. PMID: 20453858 Free PMC article.
Distinct modes of deregulation of the proto-oncogenic Cdc25A phosphatase in human breast cancer cell lines.
Löffler H, Syljuåsen RG, Bartkova J, Worm J, Lukas J, Bartek J. Löffler H, et al. Among authors: bartkova j. Oncogene. 2003 Nov 6;22(50):8063-71. doi: 10.1038/sj.onc.1206976. Oncogene. 2003. PMID: 14603247
DNA damage response mediators MDC1 and 53BP1: constitutive activation and aberrant loss in breast and lung cancer, but not in testicular germ cell tumours.
Bartkova J, Horejsí Z, Sehested M, Nesland JM, Rajpert-De Meyts E, Skakkebaek NE, Stucki M, Jackson S, Lukas J, Bartek J. Bartkova J, et al. Oncogene. 2007 Nov 22;26(53):7414-22. doi: 10.1038/sj.onc.1210553. Epub 2007 Jun 4. Oncogene. 2007. PMID: 17546051
Replication stress and oxidative damage contribute to aberrant constitutive activation of DNA damage signalling in human gliomas.
Bartkova J, Hamerlik P, Stockhausen MT, Ehrmann J, Hlobilkova A, Laursen H, Kalita O, Kolar Z, Poulsen HS, Broholm H, Lukas J, Bartek J. Bartkova J, et al. Oncogene. 2010 Sep 9;29(36):5095-102. doi: 10.1038/onc.2010.249. Epub 2010 Jun 28. Oncogene. 2010. PMID: 20581868
Chk2 tumour suppressor protein in human spermatogenesis and testicular germ-cell tumours.
Bartkova J, Falck J, Rajpert-De Meyts E, Skakkebaek NE, Lukas J, Bartek J. Bartkova J, et al. Oncogene. 2001 Sep 13;20(41):5897-902. doi: 10.1038/sj.onc.1204746. Oncogene. 2001. PMID: 11593395
147 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback